NMO SPECTRUM DISORDER
Clinical trials for NMO SPECTRUM DISORDER explained in plain language.
Never miss a new study
Get alerted when new NMO SPECTRUM DISORDER trials appear
Sign up with your email to follow new studies for NMO SPECTRUM DISORDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug B001 aims to tame rare autoimmune brain disease
Disease control Recruiting nowThis study is testing an experimental drug called B001 in people with a specific form of NMOSD, a rare disease where the immune system attacks the optic nerves and spinal cord. The main goal is to check the drug's safety and how the body processes it. About 45 adults who have had…
Matched conditions: NMO SPECTRUM DISORDER
Phase: EARLY_PHASE1 • Sponsor: Shanghai Pharmaceuticals Holding Co., Ltd • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
New antibody therapies tested for rare nerve disease
Disease control Recruiting nowThis study looks at how well antibody-based medicines work for people with a rare nerve disease called neuromyelitis optica (NMO). About 200 adults in China will take part, and researchers will track relapses, disability, and side effects over time. The goal is to find safer and …
Matched conditions: NMO SPECTRUM DISORDER
Sponsor: Tongji Hospital • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
Could zapping the brain ease nerve pain in NMOSD?
Symptom relief Recruiting nowThis study tests a non-invasive brain stimulation method called tTIS to see if it can safely reduce nerve pain in people with neuromyelitis optica spectrum disorder (NMOSD). Researchers will enroll 12 participants who have had persistent pain for at least 3 months. The goal is to…
Matched conditions: NMO SPECTRUM DISORDER
Phase: NA • Sponsor: Tang-Du Hospital • Aim: Symptom relief
Last updated May 26, 2026 02:48 UTC
-
AI set to revolutionize MS care with 7,000-Patient data study
Knowledge-focused Recruiting nowThis study gathers health data from 7,000 people with multiple sclerosis and related conditions. The goal is to use this information to train artificial intelligence that can help doctors better diagnose, predict disease progression, and tailor treatments. No new treatments are t…
Matched conditions: NMO SPECTRUM DISORDER
Sponsor: icometrix • Aim: Knowledge-focused
Last updated May 26, 2026 03:10 UTC